Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Global Prospective Observational Registry of Patients With Pompe Disease

NCT06121011 is registered in ClinicalTrials.gov with Amicus Therapeutics as lead sponsor.

NCT NCT06121011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06121011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Global Prospective Observational Registry of Patients With Pompe Disease
Lead sponsor
Amicus Therapeutics
Phase
Observational
Overall status
Recruiting
Start date
February 16, 2024
Completion date
December 20, 2034
Enrollment
500 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

pompe disease